Therapheutic relevance of the sphingolipid-metabolizing enzyme acid sphingomyelinase as a new pathogenetic factor in Duchenne muscular dystrophy

Project

Overview

Contributors

PERROTTA CRISTIANA   Scientific Manager  

Departments involved

Type

INTLI - Finanziamenti internazionali

Funder

AFM-TELETHON - ASS. FRANCAISE CONTRE LES MYOPATHIES
External Organization Funding Organization

Date/time interval

April 4, 2017 - April 3, 2018

Project duration

12 months